Is NNVC Starting a New Uptrend - Consistent Gain Investment Strategies Emerge - beatles.ru
2 days ago • Google News
NanoViricides Inc (NNVC)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 25.39M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
0
52W High
$ 2.34
52W Low
$ 0.94
Dividend Yield
0.00%
Beta
0.96
Technicals
50-Day MA
1.5264
200-Day MA
1.3803
52 Week High
2.34
52 Week Low
0.94
About NNVC
NanoViricides, Inc., a clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections.
Employees
7
Headquarters
Shelton, CT
CEO
Dr. Anil R. Diwan Ph.D.